Eithne Costello

Circulating microRNAs as potential markers of human drug-induced liver injury

Philip J. Starkey Lewis, James W. Dear, Vivien Platt et al. · Hepatology · 2011 · 516 citations

Veterinary Medicine, Molecular Medicine, Pharmacology +16

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

Gary Middleton, Paul Silcocks, Trevor F. Cox et al. · The Lancet Oncology · 2014 · 374 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial

William Greenhalf, Paula Ghaneh, John P. Neoptolemos et al. · JNCI Journal of the National Cancer Institute · 2013 · 333 citations

Medicine, Cancer Biology, Oncology +16

Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma

Ashton A. Connor, Robert E. Denroche, Gun Ho Jang et al. · JAMA Oncology · 2016 · 301 citations · Full text

Medicine, Immunology, Oncology +17

GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer

Paola Martinelli, Enrique Carrillo de Santa Pau, Trevor F. Cox et al. · Gut · 2016 · 278 citations · Full text

Medicine, Cancer Biology, Oncology +11